Parallax Volatility Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$586K Sell
19,071
-1,998
-9% -$58.5K ﹤0.01% 1035
2025
Q4
$610K Sell
21,069
-2,184
-9% -$65.6K ﹤0.01% 1195
2025
Q3
$646K Sell
23,253
-12,498
-35% -$316K ﹤0.01% 1205
2025
Q2
$871K Sell
35,751
-72,544
-67% -$1.59M ﹤0.01% 1089
2025
Q1
$2.25M Buy
108,295
+75,045
+226% +$1.89M 0.01% 840
2024
Q4
$783K Buy
33,250
+24,589
+284% +$605K ﹤0.01% 1399
2024
Q3
$222K Sell
8,661
-105
-1% -$2.67K ﹤0.01% 1675
2024
Q2
$206K Sell
8,766
-23,661
-73% -$597K ﹤0.01% 1603
2024
Q1
$933K Buy
32,427
+10,505
+48% +$316K ﹤0.01% 1258
2023
Q4
$719K Sell
21,922
-8,057
-27% -$219K ﹤0.01% 1508
2023
Q3
$835K Buy
29,979
+7,785
+35% +$255K ﹤0.01% 1431
2023
Q2
$757K Sell
22,194
-4,017
-15% -$126K ﹤0.01% 1510
2023
Q1
$788K Buy
26,211
+26,210
+2,621,000% +$812K ﹤0.01% 1595
2022
Q4
$28 Hold
1
﹤0.01% 2816
2022
Q3
$0 Sell
1
-170,565
-100% -$6.26M ﹤0.01% 3046
2022
Q2
$5.37M Buy
170,566
+109,079
+177% +$3.81M 0.01% 951
2022
Q1
$2.82M Buy
+61,487
New +$2.93M ﹤0.01% 1227

Other funds holding ARKG

Parallax Volatility Advisers's ARKG Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 9.5% in Q1 2026, selling an estimated $58.5K and leaving 19,071 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Parallax Volatility Advisers first reported a position in ARKG in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.37M in Q2 2022. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Parallax Volatility Advisers held 19,071 shares of ARK Genomic Revolution ETF worth $586K as of Q1 2026.
  • Parallax Volatility Advisers sold 1,998 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $58.5K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1035 holding.
  • Parallax Volatility Advisers first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 17 quarters since.
  • Parallax Volatility Advisers's ARK Genomic Revolution ETF position peaked at $5.37M in Q2 2022.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.